Ferroptosis: a new promising target for hepatocellular carcinoma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ferroptosis: a new promising target for hepatocellular carcinoma therapy

Published:2023-12-05 Issue: Volume: Page:
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Xu Qiaoping,Ren Lanqi,Ren Ning,Yang Yibei,Pan Junjie,Zheng Yu,Wang Gang

Funder

Key Medical Discipline of Hangzhou City

Key Medical Discipline of Zhejiang Province

Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province

Zhejiang Province Medical and Health Science and Technology Program

Zhejiang Traditional Chinese Medicine Science and Technology Project

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11010-023-04893-y.pdf

Reference137 articles.

1. He P, Wan H, Wan J, Jiang H, Yang Y, Xie K et al (2022) Systemic therapies in hepatocellular carcinoma: existing and emerging biomarkers for treatment response. Front Oncol 12:1015527. https://doi.org/10.3389/fonc.2022.1015527

2. Zhou J, Li LU, Fang LI, Xie H, Yao W, Zhou X et al (2016) Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells. Oncol Lett 12:516–522. https://doi.org/10.3892/ol.2016.4639

3. Pang BY, Leng Y, Wang X, Wang YQ, Jiang LH (2023) A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma. Ann Med 55:42–61. https://doi.org/10.1080/07853890.2022.2153163

4. Huang Z, Xia H, Cui Y, Yam JWP, Xu Y (2023) Ferroptosis: from basic research to clinical therapeutics in hepatocellular carcinoma. J Clin Transl Hepatol 11:207–218. https://doi.org/10.14218/jcth.2022.00255

5. Bae C, Kim H, Kook YM, Lee C, Kim C, Yang C et al (2022) Induction of ferroptosis using functionalized iron-based nanoparticles for anti-cancer therapy. Mater Today Bio 17:100457. https://doi.org/10.1016/j.mtbio.2022.100457

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside;Clinical and Experimental Medicine;2024-07-03

2. Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-07

3. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy;Biomedicine & Pharmacotherapy;2024-04

4. Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk;Cancer Letters;2024-04

5. Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma;Frontiers in Pharmacology;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3